Sutib 12.5MG Capsule (7’s) is a targeted therapy medication that contains Sunitinib as its active ingredient, specifically formulated to combat certain types of cancer. This drug is primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and gastrointestinal stromal tumors (GISTs) that cannot be surgically removed or have metastasized. Each capsule contains 12.5 mg of Sunitinib, which works by inhibiting specific proteins that promote tumor growth and blood vessel formation, thereby slowing down the progression of cancer. Sutib is available in a convenient capsule form, making it easy for patients to incorporate into their daily medication regimen. As a potent anti-cancer agent, Sutib is essential for patients seeking effective treatment options for their conditions, and it is crucial to follow medical advice regarding its use to maximize its benefits.